Examkin

Question

Difficulty: HardPharmacologic Interventions

A 71-year-old man is brought to the emergency department from a skilled nursing facility with profound lethargy and fever. His temperature is 39.4°C (102.9°F), heart rate is 128/min, respiratory rate is 24/min, and blood pressure is 74/38 mmHg. Oxygen saturation is 95% on ambient air. Physical examination reveals dry mucous membranes, delayed capillary refill, and suprapubic tenderness. Laboratory studies show a white blood cell count of 19,000/mm³ and a serum lactate of 4.8 mmol/L. Blood and urine cultures are obtained, and broad-spectrum intravenous antibiotics are initiated for suspected urosepsis. The clinical team anticipates a prolonged resuscitation course and outlines a step-wise treatment pathway to maintain a mean arterial pressure (MAP) greater than 65 mmHg. Arrange the following pharmacologic interventions in the correct sequential order of administration according to guideline-directed therapy for septic shock.

  1. 1Rapid infusion of 30 mL/kg of balanced crystalloid solution
  2. 2Initiation of norepinephrine continuous infusion
  3. 3Addition of vasopressin continuous infusion
  4. 4Administration of intravenous hydrocortisone

Answer

The correct sequence for managing septic shock is: 1) Rapid infusion of 30 mL/kg of balanced crystalloid solution, 2) Initiation of norepinephrine continuous infusion, 3) Addition of vasopressin continuous infusion, and 4) Administration of intravenous hydrocortisone.
The Surviving Sepsis Campaign guidelines dictate a strict sequence for hemodynamic stabilization. The cornerstone of initial therapy is volume expansion with at least 30 mL/kg of intravenous crystalloid within the first 3 hours. If the patient remains hypotensive (MAP < 65 mmHg) after the fluid challenge, a vasopressor is indicated, with norepinephrine being the preferred first-line agent. If the MAP target is still not achieved despite escalating doses of norepinephrine (typically > 0.25-0.5 mcg/kg/min), the addition of a second vasopressor, specifically vasopressin, is recommended to augment blood pressure and decrease the norepinephrine requirement. Finally, if hemodynamic stability cannot be achieved despite adequate fluid resuscitation and vasopressor therapy, intravenous hydrocortisone (typically 200 mg/day) is administered to treat potential critical illness-related corticosteroid insufficiency (CIRCI).

Step-by-Step Solution

1
Evaluate initial hemodynamic status and initiate fluid resuscitation.
A crystalloid bolus is administered.
Intravascular volume depletion must be corrected first to optimize cardiac preload and stroke volume.
2
Re-evaluate the mean arterial pressure (MAP) and initiate the first-line vasopressor.
Norepinephrine is started.
The MAP remains below 65 mmHg despite fluid loading, requiring strong alpha-1 agonism to increase systemic vascular resistance.
3
Escalate vasopressor therapy if the MAP remains sub-target on high-dose primary agents.
Vasopressin is added.
Vasopressin helps achieve MAP goals while sparing escalating doses of norepinephrine and its associated adverse effects (e.g., tachyarrhythmias, profound ischemia).
4
Address potential adrenal insufficiency in refractory shock.
Intravenous hydrocortisone is administered.
Refractory shock unresponsive to adequate fluids and dual vasopressors requires stress-dose steroids to restore vascular responsiveness.

Key Concept

Step-wise pharmacologic management of septic shock
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic